Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives Consensus Rating of “Hold” from Analysts
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) has been assigned an average rating of “Hold” from the fourteen research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and six have assigned a buy recommendation to the […]
10 Jan 09:04 · The Markets Daily